Your shopping cart is currently empty

BRD1172 (ML320) is a selective inhibitor of GSK3β, exhibiting an IC50 of 24 nM, demonstrating greater potency against GSK3β compared to CDK5. It significantly inhibits GSK3β-mediated Tau phosphorylation in SH-SY5Y cells and reduces the negative regulation by GSK3β on β-catenin degradation and TCF/LEF promoter activity. BRD1172 is applicable in research on Alzheimer's disease, cardiac hypertrophy, and cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | BRD1172 (ML320) is a selective inhibitor of GSK3β, exhibiting an IC50 of 24 nM, demonstrating greater potency against GSK3β compared to CDK5. It significantly inhibits GSK3β-mediated Tau phosphorylation in SH-SY5Y cells and reduces the negative regulation by GSK3β on β-catenin degradation and TCF/LEF promoter activity. BRD1172 is applicable in research on Alzheimer's disease, cardiac hypertrophy, and cancer. |
| Targets&IC50 | GSK-3β:24 nM |
| Synonyms | ML320 |
| Molecular Weight | 391.39 |
| Formula | C20H20F3N3O2 |
| Cas No. | 1597438-86-2 |
| Smiles | C(F)(F)(F)C1=C2[C@@H](C3=C(NC2=NN1)CC(C)(C)CC3=O)C4=C(OC)C=CC=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.